Stocks within Assessment: KeyCorp (NYSE:KEY), AbbVie Inc. (NYSE:ABBV)

0
36

KeyCorp (NYSE:KEY):

Last Trade:

KeyCorp (NYSE:KEY) ended its previous trading session at $17.45 with the Loss of 0%. The company’s market cap is $18.09 Billion, and the average volume is $12.58 Million. The 52-Week High range of the stock is $22.4, while the 52-week low range is $16.48. The Price to Sales (P/S) of the stock is 3.85, while P/B (Price to Book) stands at 1.31. When we look at the Volatility of the company, Week Volatility is at 3.13% whereas Month Volatility is at 2.65%.


For the ongoing Fiscal Quarter, 25 analysts have an average earnings forecast of $0.47 per share. According to the Analysts, the Low Earnings estimate for the current quarter is $0.44, while the High earnings estimate is $0.51.Comparatively, EPS for the same quarter last year was $0.4.


According to 19 analysts, the Average Revenue Estimate for the current Fiscal quarter is $1.65 Billion and the Low Revenue estimate is $1.63 Billion, while the High Revenue estimate is $1.67 Billion.


KeyCorp (NYSE:KEY) analysts on average have given a price target of $22.17 on KEY stock.


According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 2 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.


AbbVie Inc. (NYSE:ABBV):


Previous Trade:

AbbVie Inc. (NYSE:ABBV) shares declined 0% and ended the day at $90.55. Its 52-week high and low range is between $125.86 and $77.5. The company’s outstanding shares are 1.51 Billion. The volume of the company in the last trading session was 0. The stock has a market cap of 136.82 Billion. The Stock shows P/E value of 17.81 and Forward P/E of 10.39.


According to Finviz reported data, The SMA20 of the stock is at 1.99%, SMA50 is 2.13 percent, while SMA200 is -6.15%. The stock is currently has its Return on Assets (ROA) value of 11.2 Percent. The Return on Investment and Return on Equity (ROE) values are 17.8 percent and 0 percent, respectively.


The company’s ATR (Average True Range) is 2.94. The Weekly Volatility is 3.40% and the Monthly Volatility is 3.19%.


When we look at the Analyst Recommendations of the stock, the company has 2.6 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.


AbbVie Inc. (NYSE:ABBV) analysts on average have given a price target of $22.17 on ABBV stock.


AbbVie Inc.’s Average Earnings Estimate for the current quarter is $1.93, according to consensus of 14 analysts. The low EPS estimate is $1.86, while the high EPS estimate is $2.03.


Average Revenue Estimate of the company for the current Fiscal Quarter is $8.36 Billion, according to consensus of 11 analysts. The higher end of the revenue estimate is $8.57 Billion and the lower end is $8.26 Billion.

SHARE

LEAVE A REPLY